1Ritz E,Orth SR.Nephropathy in patients with type 2 diabetes mellitus[J].N Engl J Med,1999,341:1127.
2Strippoli GF,Di Paolo S,Cincione R,et al.Clinical and therapeutic aspects of diabetic nephropathy[J].J Nephrol,2003,16:487-499.
3Savage S,Nagel NJ,Estacio RO,et al.Clinical factors associated with urinary albumin excretion in type II diabetes[J].Am J Kidney Dis,1995,25:836-844.
4Klahr S.The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease[J].N Engl J Med,1993,329:1459.
6Di Paolo S,Gesualdo L,Ranieri E,et al.High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells[J].Am J Pathol,1996,149:2095-2106.
7Ravid M,Brosh D,Levi Z,et al.Use of enalapril to attenuate decline in renal function in normotensive,normoalbuminuric patients with type II diabetes mellitus.A randomized controlled trial[J].Ann Intern Med ,1998,128:982-988.
8Strippoli GF,Craig JC,Craig M,et al.Antihypertensive agents for preventing diabetic nephropathy and retarding its progression:a systematic review of randomized controlled trials (RCTs) [J].Nephrology,2002,7 (suppl XX):S63.
9Elisaf M,Mikhailidis DP.Statins and renal function[J].Angiology ,2002,53:493-502.
10Nabakov A,Amann K,Wagner JH,et al.Influence of specific and non-specific endothelin receptorantagonists on renal morphology in rats with surgical renal ablation[J].Nephrol Dial Transplant,1996,11:514-520.
